NCT04021784

Brief Summary

The primary aim of this study is to investigate and describe the limited efficacy of the Spring Distraction System (SDS) and Bilateral One Way Rod (NEMOST) in maintaining curve reduction without repeat lengthening procedures and complications. Secondary aims are to describe growth of the instrumented spine, health-related quality of life, and to compare both devices.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 6, 2019

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 13, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 16, 2019

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 13, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 13, 2023

Completed
Last Updated

June 5, 2023

Status Verified

June 1, 2023

Enrollment Period

3.9 years

First QC Date

June 13, 2019

Last Update Submit

June 1, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Limited-efficacy of SDS and NEMOST in terms of curve correction maintenance

    Changes in cobb angle on radiographs post-op and at 4 weeks, 3 months, 6 months and 12 months follow-up (FU). A maximum of 5 degrees increase will be the threshold to define maintenance.

    Until 1 year post-operatively

  • Incidence of possible Treatment-Emergent Serious Adverse Events of SDS and NEMOST

    Reported treatment related Serious Adverse Events (SAEs) per-operatively and at 4 weeks, 3 months, 6 months and 12 months FU.

    Until 1 year post-operatively

Secondary Outcomes (12)

  • Limited-efficacy of SDS and NEMOST in terms of spinal length

    Until 1 year post-operatively

  • SDS vs. NEMOST with respect to limited-efficacy in terms of curve correction maintenance

    Until 1 year post-operatively

  • SDS vs. NEMOST with respect to limited-efficacy in terms of spinal length

    Until 1 year post-operatively

  • SDS vs. NEMOST with respect to the development of the sagittale profile and instrumented thoracic kyphosis

    Until 1 year post-operatively

  • SDS vs. NEMOST with respect to surgery time

    Until 1 year post-operatively

  • +7 more secondary outcomes

Study Arms (2)

Spring Distraction System (SDS)

EXPERIMENTAL

The SDS will be placed and fits around a standard rod of 5.5mm.

Device: SDS

Necker Enfants Malade OSTeosynthesis (NEMOST)

EXPERIMENTAL

The NEMOST is a one-way-rod that uses a ratchet type of locking mechanism. Both NEMOST devices should be placed in parallel, on the two fixator rods that are connected with a cross connector

Device: NEMOST

Interventions

SDSDEVICE

The patient is implanted with SDS.

Spring Distraction System (SDS)
NEMOSTDEVICE

The patient is implanted with NEMOST.

Necker Enfants Malade OSTeosynthesis (NEMOST)

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Non ambulant
  • Neuromuscular or syndromal scoliosis
  • Progressive scoliosis indicated for bipolar fixation extending to the pelvis
  • Diagnosis of scoliosis before age 10
  • Patient under 12 and open triradiate cartilage (usually closes around 12 years for girls and 14 years for boys)
  • Main curve proximal end vertebra below Th 3
  • Non rigid curve
  • Patients who have an indication for a primary surgery

You may not qualify if:

  • Ambulant
  • Patients with closed triradiate cartilage
  • Patients with a skeletal dysplasia that effects growth (Achondroplasia, SED)
  • Patients with a systemic disease which severely influences bone quality e.g. osteogenesis imperfecta, metabolic diseases
  • Patients with soft tissue weakness (Ehler Danlos, Marfan, Neurofibromatosis, Prader Willi)
  • Patients that have a congenital anomaly of the spine of more than 5 vertebrae
  • Patients with an active systemic disease such as JIA, HIV, oncologic treatment
  • Patients with a previous surgical fusion of the spine
  • Patients that are expected to be lost to FU due to e.g. likely to immigrate within 1 year.
  • Patients that have had a previous spine surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Amsterdam UMC

Amsterdam, North Holland, 1105AZ, Netherlands

Location

Erasmus Medical Center

Rotterdam, Netherlands

Location

UMC Utrecht

Utrecht, 3584CX, Netherlands

Location

Related Publications (1)

  • Lemans JVC, Tabeling CS, Scholten EP, Stempels HW, Miladi L, Castelein RM, Kruyt MC. Surgical treatment of neuromuscular Early Onset Scoliosis with a bilateral posterior one-way rod compared to the Spring Distraction System: study protocol for a limited-efficacy Randomized Controlled Trial (BiPOWR). BMC Musculoskelet Disord. 2023 Jan 10;24(1):20. doi: 10.1186/s12891-022-06048-4.

Related Links

Study Officials

  • Moyo C Kruyt, MD, PhD

    UMC Utrecht

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The patient is blinded to the medical device until after surgery. This is done to prevent selection bias through withdrawal. Patients are unblinded post-operatively, to enable accurate patient counseling with radiographs, on which the implant can be clearly seen.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Half of the patients will be implanted with SDS system, the other half will be implanted with NEMOST.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Orthopaedic surgeon

Study Record Dates

First Submitted

June 13, 2019

First Posted

July 16, 2019

Study Start

May 6, 2019

Primary Completion

March 13, 2023

Study Completion

March 13, 2023

Last Updated

June 5, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

Locations